LSL Pharma Group, Inc. () Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

High Debt Company with a Debt to Equity ratio (avg) at times

Poor long term growth as Net Sales has grown by an annual rate of 77.00% over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times
The company has been able to generate a Return on Equity (avg) of 6.95% signifying low profitability per unit of shareholders funds

Positive results in Jun 24

With ROE of 14.63%, it has a very attractive valuation with a 1.82 Price to Book Value

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Industry

Gems, Jewellery And Watches

Market cap

CAD 42 Million (Micro Cap)

P/E

12.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.78

Return on Equity

14.63%

Price to Book

1.73

Revenue and Profits:

Net Sales:

7 Million

(Quarterly Results - Jun 2025)

Net Profit:

0 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

0.0%

6 Months

-2.6%

1 Year

-6.25%

2 Years

-9.64%

3 Years

-62.5%

4 Years

-62.5%

5 Years

-62.5%

LSL Pharma Group, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

77.00%

EBIT Growth (5y)

109.95%

EBIT to Interest (avg)

-0.87

Debt to EBITDA (avg)

8.08

Net Debt to Equity (avg)

0.75

Sales to Capital Employed (avg)

0.38

Tax Ratio

1.43%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

0.76%

ROE (avg)

6.95%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.82

EV to EBIT

57.35

EV to EBITDA

20.36

EV to Capital Employed

1.46

EV to Sales

2.73

PEG Ratio

0.10

Dividend Yield

ROCE (Latest)

2.55%

ROE (Latest)

14.63%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Sideways

Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Mildly Bullish

Dow Theory

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 71.43% vs 110.00% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 20.00% vs 83.87% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7.20",
          "val2": "4.20",
          "chgp": "71.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.00",
          "val2": "0.20",
          "chgp": "400.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.70",
          "val2": "0.40",
          "chgp": "75.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.40",
          "val2": "-0.50",
          "chgp": "20.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "42.10%",
          "val2": "-33.90%",
          "chgp": "7.60%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "17.70",
          "val2": "10.00",
          "chgp": "77.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.90",
          "val2": "-3.00",
          "chgp": "163.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.90",
          "val2": "1.80",
          "chgp": "5.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-2.60",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3.30",
          "val2": "-8.50",
          "chgp": "138.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "22.90%",
          "val2": "-410.50%",
          "chgp": "43.34%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

7.20

4.20

71.43%

Operating Profit (PBDIT) excl Other Income

1.00

0.20

400.00%

Interest

0.70

0.40

75.00%

Exceptional Items

0.00

Consolidate Net Profit

-0.40

-0.50

20.00%

Operating Profit Margin (Excl OI)

42.10%

-33.90%

7.60%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is 71.43% vs 110.00% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 20.00% vs 83.87% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

17.70

10.00

77.00%

Operating Profit (PBDIT) excl Other Income

1.90

-3.00

163.33%

Interest

1.90

1.80

5.56%

Exceptional Items

0.00

-2.60

100.00%

Consolidate Net Profit

3.30

-8.50

138.82%

Operating Profit Margin (Excl OI)

22.90%

-410.50%

43.34%

USD in Million.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Consolidated Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results

Company CV

About LSL Pharma Group, Inc.

LSL Pharma Group, Inc.

Gems, Jewellery And Watches

No Details Available.

Company Coordinates

No Company Details Available